Literature DB >> 10217256

Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore.

H M Schipper1, L Bernier, K Mehindate, D Frankel.   

Abstract

Little is currently known concerning the mechanisms responsible for the excessive deposition of redox-active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non-transferrin-derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up-regulation of the stress protein heme oxygenase-1 (HO-1) is both necessary and sufficient for mitochondrial iron trapping in dopamine-challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non-transferrin-derived iron into mitochondria of dopamine-stimulated and HO-1-transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by "stressed" astroglial mitochondria (e.g., using HO-1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217256     DOI: 10.1046/j.1471-4159.1999.0721802.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

3.  Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.

Authors:  Bryan J McCranor; Min Jung Kim; Nicole M Cruz; Qian-Li Xue; Alan E Berger; Jeremy D Walston; Curt I Civin; Cindy N Roy
Journal:  Blood Cells Mol Dis       Date:  2013-10-09       Impact factor: 3.039

4.  Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation.

Authors:  Pablo Diaz-Amarilla; Ernesto Miquel; Andrés Trostchansky; Emiliano Trias; Ana M Ferreira; Bruce A Freeman; Patricia Cassina; Luis Barbeito; Marcelo R Vargas; Homero Rubbo
Journal:  Free Radic Biol Med       Date:  2016-03-22       Impact factor: 7.376

5.  Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.

Authors:  Wei Song; Hillel Zukor; Adrienne Liberman; Sagi Kaduri; Zoe Arvanitakis; David A Bennett; Hyman M Schipper
Journal:  Exp Neurol       Date:  2014-01-15       Impact factor: 5.330

Review 6.  Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim.

Authors:  Hyman M Schipper
Journal:  J Neural Transm (Vienna)       Date:  2010-06-20       Impact factor: 3.575

7.  Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Eugenio Barone; Fabio Di Domenico; Rukhsana Sultana; Raffaella Coccia; Cesare Mancuso; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2012-04-17       Impact factor: 7.376

8.  Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases.

Authors:  H M Schipper
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

9.  Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative.

Authors:  Katalin Prokai-Tatrai; Pal Perjesi; Nilka M Rivera-Portalatin; James W Simpkins; Laszlo Prokai
Journal:  Steroids       Date:  2007-11-04       Impact factor: 2.668

Review 10.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.